References
Halbreich U, Kahn LS. Atypical depression, somatic depression and anxious depression in women: are they gender-preferred phenotypes? J Affect Disord 2007;102(1–3):245–58.
Silverstein B. Gender differences in the prevalence of somatic versus pure depression: a replication. Am J Psychiatry 2002;159(6):1051–2.
Meltzer CC, Price JC, Mathis CA, et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004;29(12):2258–65.
Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 2000;27(5):499–507.
Sargent PA, Kjaer KH, Bench CJ, et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000;57(2):174–80.
Parsey RV, Oquendo MA, Ogden RT, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006;59(2):106–13.
Jovanovic H, Lundberg J, Karlsson P, et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 2008;39(3):1408–19.
Parsey RV, Oquendo MA, Simpson NR, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 2002;954(2):173–82.
Stein P, Savli M, Wadsak W, et al. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-(11)C]WAY-100635. Eur J Nucl Med Mol Imaging. 2008. doi:10.1007/s00259-008-0850-x.
Chefer SI, Spinelli S, Carson RE, Jagoda EM, Suomi SJ, Stein EA. Gender differences in 5HT1A receptor density and affinity measured by [18F]FPWAY and PET in juvenile rhesus monkeys. NeuroImage 2008;41(Supplement 2):T147.
Hirvonen J, Karlsson H, Kajander J, et al. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008;11(4):465–76.
Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 2006;31(8):1745–9.
Moses-Kolko EL, Price JC, Thase ME, et al. Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 2007;61(7):523–30.
Lundberg J, Borg J, Halldin C, Farde L. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl) 2007;195(3):425–33.
Parsey RV, Ogden RT, Tin A, et al. Altered serotonin 1A binding potential in major depression using [11C]WAY 100635: a second patient cohort. NeuroImage 2008;41(Supplement 2):T44.
Author information
Authors and Affiliations
Corresponding author
Additional information
This editorial commentary refers to the article http://dx.doi.org/10.1007/s00259-008-0850-x
Rights and permissions
About this article
Cite this article
Becherer, A. The molecular background of sex difference in depressive disorders: still an enigma. Eur J Nucl Med Mol Imaging 35, 2156–2158 (2008). https://doi.org/10.1007/s00259-008-0928-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-008-0928-5